Product logins

Find logins to all Clarivate products below.


Minimally Invasive Vertebral Compression Fracture Treatments | Market Insights | Global | 2021

The global MIVCF treatment device market will be driven mainly by increasingly positive clinical opinion of MIVCF procedures. Furthermore, the growing aging and obese populations across the globe, underserved populations, as well as new product launches and increasing adoption of advanced premium-priced technologies will help overcome obstacles such as unfavorable reimbursement environments. Therefore, the market will see modest growth through 2029. However, the market will be negatively affected in the short term by the global COVID-19 pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for MIVCF treatment devices in the global region across a 10-year period.

Related Medtech Insights Reports

Report
Minimally Invasive Vertebral Compression Fracture Treatments – Market Insights – Global
Despite the negative impact of COVID-19, the global MIVCF treatment market is expected to show modest growth through 2033, driven by moderate growth in the Asia Pacific region and sustained…
Report
Minimally Invasive Vertebral Compression Fracture Treatments | Market Insights | Global | 2023
Despite the short-term negative impact of the COVID-19 pandemic, the global market for MIVCF treatments will show particularly strong growth through 2031, reflecting the moderate growth in the…
Report
Pulmonology Devices | Market Insights | US | 2021
​In 2020, the US pulmonology device market will be moderately impacted by the COVID-19 pandemic but will nevertheless grow over the forecast period, fueled by bronchoscopy procedure volume…
Report
Biosurgical Agents | Market Insights | Latin America | 2021
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by …
Report
Biosurgical Agents | Market Insights | Europe (Supplemental) | 2021
The COVID-19 pandemic will negatively impact the European biosurgical agent market in the short term. Once the market stabilizes, the biosurgical agent market in Europe will grow at a modest…